DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Connolly SJ, Eikelboom JW, Bosch J. et al; COMPASS Investigators.
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
Lancet 2018;
391 (10117): 205-218
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.